Fermi Inc. — Investor Relations & Filings
Fermi Inc. is a company developing next-generation electric grids and large-scale artificial intelligence (AI) data center campuses. The company's primary project is an advanced energy and AI campus designed to deliver 11 gigawatts of highly redundant power. This infrastructure utilizes a hybrid energy model that integrates nuclear, natural gas, and solar power generation. Fermi's business model involves leasing data center space and providing dedicated, on-site power to clients with significant computational requirements, such as AI laboratories and cloud providers. By co-locating power generation with data centers, the company aims to directly address the substantial energy demands of the AI sector.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| First Quarter 2026 Earnings Release & Call Date | 2026-05-11 | English | |
| 8-K - Fermi Inc. (0002071778) (Filer) | 2026-05-06 | English | |
| Form 8-K | 2026-05-06 | English | |
| Fermi Proxy Response Press Release | 2026-05-06 | English | |
| DFAN14A - Fermi Inc. (0002071778) (Subject) | 2026-05-05 | English | |
| 8-K - Fermi Inc. (0002071778) (Filer) | 2026-05-05 | English |
Browse filings by year
2 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 44893805 | First Quarter 2026 Earnings Release & Call Date | 2026-05-11 | English | ||
| 41834927 | 8-K - Fermi Inc. (0002071778) (Filer) | 2026-05-06 | English | ||
| 41743717 | Form 8-K | 2026-05-06 | English | ||
| 41743714 | Fermi Proxy Response Press Release | 2026-05-06 | English | ||
| 41540295 | DFAN14A - Fermi Inc. (0002071778) (Subject) | 2026-05-05 | English | ||
| 41343035 | 8-K - Fermi Inc. (0002071778) (Filer) | 2026-05-05 | English | ||
| 41264077 | Form 8-K | 2026-05-05 | English | ||
| 39399435 | Form 8-K/A | 2026-05-01 | English | ||
| 39071215 | 8-K - Fermi Inc. (0002071778) (Filer) | 2026-04-30 | English | ||
| 39018777 | Form 8-K | 2026-04-30 | English | ||
| 39018714 | Interim CFO Appointment | 2026-04-30 | English | ||
| 34690931 | 8-K - Fermi Inc. (0002071778) (Filer) | 2026-04-20 | English | ||
| 34688999 | Fermi Inc. announcement | 2026-04-20 | English | ||
| 34688997 | FORM 8-K | 2026-04-20 | English | ||
| 34662451 | 8-K - Fermi Inc. (0002071778) (Filer) | 2026-04-17 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
PegBio Co., Ltd.
Specializes in discovering and developing innovative therap…
|
2565 | HK | Professional, scientific and te… |
|
PELL BIO-MED TECHNOLOGY CO., LTD.
Develops advanced cell and gene therapies, including CAR-T …
|
6949 | TW | Professional, scientific and te… |
|
PepGen Inc.
Develops oligonucleotide therapeutics for neuromuscular and…
|
PEPG | US | Professional, scientific and te… |
|
PERCHERON THERAPEUTICS LIMITED
Clinical-stage developer of antisense pharmaceuticals for r…
|
PER | AU | Professional, scientific and te… |
|
Perseus Proteomics Inc.
Develops antibody-based therapeutics, diagnostics, and rese…
|
4882 | JP | Professional, scientific and te… |
|
PExA AB
Develops non-invasive technology for respiratory medicine b…
|
PEXA B | SE | Professional, scientific and te… |
|
PharmaResources (Shanghai) Co., Ltd.
Integrated CRO and CDMO for small molecule drug discovery a…
|
301230 | CN | Professional, scientific and te… |
|
Pharmaron Beijing Co., Ltd
Delivers integrated R&D and manufacturing across the entire…
|
3759 | HK | Professional, scientific and te… |
|
Pharmaron Beijing Co., Ltd.
Integrated R&D provider for drug discovery, development, an…
|
300759 | CN | Professional, scientific and te… |
|
Pharos iBio Co., Ltd.
Clinical-stage biotech using AI to develop therapies for ra…
|
388870 | KR | Professional, scientific and te… |
Fermi Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17756/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17756 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17756 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17756 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17756}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Fermi Inc. (id: 17756)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.